Osmotica (NASDAQ: OSMT) is a leading global, fully-integrated specialty pharmaceutical and generics company with capabilities across the pharmaceutical lifecycle. With an attractive portfolio of marketed products and robust pipeline, Osmotica develops, manufactures and commercializes pharmaceutical products across a variety of therapeutic areas, including neuroscience, pain and women’s healthcare.
Headquarters: Bridgewater, NJ